DOPATREE
Preview
Open in TheBrain
DOPATREE
COMPANIES-ALL (COMPANY, CLIENTS, SPONSORS, SMALL, MID-SIZE, LARGE PHARMA, BIG PHARMA, BIOPHARMA, EMERGING COMPANIES, STARTUPS, START-UPS, SPIN-OFFS, SUBSIDIARIES, SUBSIDIARY, BIOTECHNOLOGY, EMERGING)
COMPANIES / LISTINGS-N
NOVARTIS
NOVARTIS / PRODUCTS / APPROVED
PLUVICTO™ (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN)
PLUVICTO / WARNINGS AND PRECAUTIONS
NEPHROTOXICITY (RENAL TOXICITY, DRUG-INDUCED)
NEPHROTOXICITY / MITIGATIONS
AVOID USE IN PATIENTS EGRF <30 ML/MIN
Parents
NEPHROTOXICITY / MITIGATIONS